# A First in Human Study of PLT012 in Participants With Solid Tumor Cancers

> **NCT07337525** · PHASE1 · RECRUITING · sponsor: **Pilatus Biosciences Inc** · enrollment: 36 (estimated)

## Conditions studied

- Advanced Malignant Solid Tumor
- Solid Tumor Cancer

## Interventions

- **DRUG:** PLT012

## Key facts

- **NCT ID:** NCT07337525
- **Lead sponsor:** Pilatus Biosciences Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-13
- **Primary completion:** 2027-09
- **Final completion:** 2028-01
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07337525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07337525, "A First in Human Study of PLT012 in Participants With Solid Tumor Cancers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07337525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*